Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats. (Q53580875)

15 May 2018

title

Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats. (English)

1 reference

15 May 2018

1 reference

Xiaoli Zhang

1

1 reference

15 May 2018

Yun Li

2

1 reference

15 May 2018

Chenzhe Liu

3

1 reference

15 May 2018

Ruifang Fan

4

1 reference

15 May 2018

Ping Wang

5

1 reference

15 May 2018

Lifei Zheng

6

1 reference

15 May 2018

Feng Hong

7

1 reference

15 May 2018

Xiaoyan Feng

8

1 reference

15 May 2018

Yue Zhang

9

1 reference

15 May 2018

Lisheng Li

10

1 reference

15 May 2018

Jinxia Zhu

11

1 reference

15 May 2018

publication date

19 February 2015

1 reference

15 May 2018

published in

Translational Research

1 reference

15 May 2018

volume

166

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

152-162

1 reference

15 May 2018

Mice lacking the dopamine transporter display altered regulation of distal colonic motility

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

D1 receptors play a major role in the dopamine modulation of mouse ileum contractility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Beta3-adrenoceptors: relaxant function and mRNA detection in smooth muscle cells isolated from the human colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

5-Hydroxytryptamine4 receptor agonists and colonic motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

The effects of prucalopride on postoperative ileus in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Aging and gastrointestinal neuromuscular function: insights from within and outside the gut.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Domperidone. A review of its use in diabetic gastropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Effect of cisapride on response fluctuations in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Serotonin in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Non-motor symptoms of Parkinson's disease: diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Gastrointestinal dysfunction in Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Upregulation of β1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Cellular distribution of NKCC2 in the gastric mucosa and its response to short-term osmotic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Beta-adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Synergistic, but not separate, stimulation of accumbal β1- and β2-adrenoceptors alters the accumbal dopamine efflux in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Investigation of neurogenic excitatory and inhibitory motor responses and their control by 5-HT(4) receptors in circular smooth muscle of pig descending colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Neuropathology of autonomic nervous system in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.003

10.1016/J.TRSL.2015.02.003

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018